Harnessing Machine Learning Approaches for the Identification, Characterization, and Optimization of Novel...

Area of Science:

• Biochemistry
• Computational Biology
• Drug Discovery

Background:

• Antimicrobial resistance (AMR) poses a significant global health crisis, with conventional antibiotics becoming increasingly ineffective against evolving pathogens.
• Antimicrobial peptides (AMPs) offer a promising alternative due to their diverse mechanisms of action, but their discovery is hindered by challenges in identification, prediction, and cost-effective screening.
• Artificial intelligence (AI) presents a transformative approach to overcome these limitations in AMP discovery.

Purpose of the Study:

• To review and synthesize recent advancements in AI-driven methodologies for the identification, prediction, and design of novel antimicrobial peptides (AMPs).
• To compare the performance of various AI models, including classical machine learning, deep learning, and large language models (LLMs), in AMP discovery.
• To propose future directions and multimodal strategies for accelerating AI-driven AMP discovery through integrated computational and experimental validation.

Main Methods:

• Review of discriminative AI models: classical machine learning, deep learning, transformer embeddings, graph/geometric encoders, structure-guided, and multi-modal hybrid learning.
• Analysis of closed-loop generative methods and large language models (LLMs) for de novo AMP design.
• Comparison of benchmark performances of AI models and validation of AI-predicted AMPs using in vitro and in vivo methods against resistant pathogens.

Main Results:

• AI enables large-scale mining of genomic data and quantitative prediction of antimicrobial activity (e.g., MIC) for AMPs.
• Various AI models, including hybrid approaches, show promise in designing AMPs with improved stability and reduced toxicity.
• AI-predicted novel AMPs have been validated experimentally against clinical and resistant pathogens, increasing experimental hit rates.

Conclusions:

• AI significantly accelerates the discovery and design of novel antimicrobial peptides (AMPs), offering a powerful tool against the AMR crisis.
• Multimodal AI strategies integrating identification, prediction, design, active learning, and mechanistic interpretability are crucial for future success.
• Collaborative computational and wet-lab validation is essential for reproducible benchmarks and interoperable data to combat multidrug-resistant pathogens.